Please login to the form below
antifungal
This page shows the latest antifungal news and features for those working in and with pharma, biotech and healthcare.
Shionogi’s novel antibiotic trial data published in The Lancet
AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a range of antimicrobial drugs, such as antibiotics, antifungals and antivirals.
Latest news
-
Shionogi's Gram-negative antibiotic launches in the UK
AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a range of antimicrobial drugs, such as antibiotics, antifungals and antivirals.
-
FDA approves Recordati’s Cushing disease drug Isturisa
Recorlev – a single-isomer version of a well-established antifungal agent – also blocks 11-beta-hydroxylase as well as other enzymes in the cortisol synthesis pathway.
-
India’s export curbs raise fears of global drug shortages
Drug exports restricted as a result of the action by India’s Directorate General of Foreign Trade (DGFT) include painkiller paracetamol, antibiotics clindamycin, erythromycin, neomycin and chloramphenicol, antifungals tinidazole, metronidazole and
-
UK biotech bags €1.5m grant for new antibiotic class
Last week, Scottish biotech NovaBiotics was awarded a £1.8m grant from Innovate UK to help support the development of Novamycin, a first-in-class antifungal compound with potential to combat
-
Insmed claims first FDA okay for limited population antibiotic
The Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD) was set up in 2016 to encourage and hasten the development of new antibiotics or antifungals for that address a limited
More from news
Approximately 3 fully matching, plus 29 partially matching documents found.
Latest Intelligence
-
Deal Watch September 2016
Basilea has granted an exclusive licence for isavuconazole (an iv and oral antifungal for invasive aspergillosis and mucomycosis) to Asahi Kasei in Japan.
-
Astellas: Ten years young
class of OAB treatments to emerge in over 30 years, the antifungal Mycamine (micafungin) and the anti-infective Dificlir - the first new treatment in 50 years for clostridium difficile or c.
-
Medius Deal Watch table for March 2015
109. Astellas / Vical. Licence and collaboration. Preclinical antifungal ASP2397. 100.
-
Pharma deals during October 2013
This proved to be the case with Dow Pharmaceutical Sciences, which had undertaken development work for Anacor on the topical antifungal tavaborole for the treatment of onychomycosis under a 2004 master
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
AstraZeneca’s John Rex joins UK biotech F2G
new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials. ... John Rex said: “I am delighted to have the opportunity to work more closely with F2G as we take the first orotomide antifungal
-
F2G appoints chief financial officer
Schmid brings over two decades of financial management experience to the antifungal drug discovery and development company, with particular expertise in mergers and acquisitions, licensing and public and private market transactions.
-
Cidara Therapeutics makes senior appointments
Balkovec has helped bring more than a dozen development candidates into clinical development, including the first approved echinocandin antifungal drug Cancidas (caspofungin), which he is additionally co-inventor of.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Neurofibromatosis: a condition that’s hard to say, but even harder to live with
- Do you know what PoTS is?
- St John & St Elizabeth Hospital “Putting people first” by Seven Stones
- OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
- Moderna’s chief exec expects to have COVID-19 vaccine data in November
- UK government invests in human challenge trials for COVID-19
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
- ...
- Can eLearning improve patient recruitment and retention?
- Some patients will still want to read pages of informed consent forms before joining a clinical trial, or want timely updates on paper rather than a notification on their phone....
- How Far Do You Want To Go?
- Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
Quick links
Infographics
